[Recommendations on clinical epilepsy treatment using gabapentin].
Krämer
G
G
Schweizerische Epilepsie-Klinik, Zürich.
Despland
P A
PA
Vassella
F
F
Wieser
H G
HG
D000085:Acetates / Q000009:adverse effects / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000588:Amines; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D000075202:Contraindications; D003509:Cyclohexanecarboxylic Acids; D004359:Drug Therapy, Combination; D004827:Epilepsy; D000077206:Gabapentin; D006801:Humans; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin
Empfehlungen zur praktischen Epilepsiebehandlung mit Gabapentin.